 |
PDBsum entry 3f5t
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Viral protein
|
PDB id
|
|
|
|
3f5t
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Nature
456:985-988
(2008)
|
|
PubMed id:
|
|
|
|
|
| |
|
X-ray structure of NS1 from a highly pathogenic H5N1 influenza virus.
|
|
Z.A.Bornholdt,
B.V.Prasad.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The recent emergence of highly pathogenic avian (H5N1) influenza viruses, their
epizootic and panzootic nature, and their association with lethal human
infections have raised significant global health concerns. Several studies have
underlined the importance of non-structural protein NS1 in the increased
pathogenicity and virulence of these strains. NS1, which consists of two
domains-a double-stranded RNA (dsRNA) binding domain and the effector domain,
separated through a linker-is an antagonist of antiviral type-I interferon
response in the host. Here we report the X-ray structure of the full-length NS1
from an H5N1 strain (A/Vietnam/1203/2004) that was associated with 60% of human
deaths in an outbreak in Vietnam. Compared to the individually determined
structures of the RNA binding domain and the effector domain from non-H5N1
strains, the RNA binding domain within H5N1 NS1 exhibits modest structural
changes, while the H5N1 effector domain shows significant alteration,
particularly in the dimeric interface. Although both domains in the full-length
NS1 individually participate in dimeric interactions, an unexpected finding is
that these interactions result in the formation of a chain of NS1 molecules
instead of distinct dimeric units. Three such chains in the crystal interact
with one another extensively to form a tubular organization of similar
dimensions to that observed in the cryo-electron microscopy images of NS1 in the
presence of dsRNA. The tubular oligomeric organization of NS1, in which residues
implicated in dsRNA binding face a 20-A-wide central tunnel, provides a
plausible mechanism for how NS1 sequesters varying lengths of dsRNA, to counter
cellular antiviral dsRNA response pathways, while simultaneously interacting
with other cellular ligands during an infection.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1: H5N1 NS1 structure. a, Cartoon representation of
the H5N1 NS1 structure as viewed looking across (top) and down
onto (bottom) the main -helix
of the RBD (aquamarine) that is implicated in dsRNA binding. The
ED is coloured green, and the linker region orange; shown as
orange dashed lines are 5 residues (75–79) not well defined in
the electron density map. b, Structural alignment of H5N1 NS1
RBD (aquamarine) with H3N1 NS1 RBD^6 (ruby: PDB ID, 1AIL), and
c, alignment of the H5N1 NS1 ED (green) with H1N1 NS1 ED^7
(ruby: PDB ID, 2GX9). In both b and c the alignments are
oriented to display the areas of greatest deviation, namely the
V22F conformational change in a loop region observed in the H5N1
RBD (b), and the movement of the -sheets
in the H5N1 ED (c), both indicated by black arrows.
|
 |
Figure 2.
Figure 2: RBD and ED dimer formation, and the NS1 chain. a,
The RBD and ED of each NS1 molecule separately interact with
their respective domains from the neighbouring NS1 molecules,
related by crystallographic two-fold axes (perpendicular to
plane of the paper indicated the black ovals), resulting in the
formation of a chain of NS1 with alternating RBD and ED dimers.
The two-fold related NS1 molecules are coloured separately in
yellow and green. The residues critical to dsRNA (residues 38
and 41)^16 and CPSF (conserved residues F103, M106 and
GLEWN183-187) binding^14, ^15, ^19 are coloured in blue and red,
respectively. b, Superposition of H5N1 RBD dimer with the H3N2
RBD^6 dimer (in ruby; PDB ID, 1AIL); each protomeric subunit in
the H5N1 RBD dimer is coloured differently in yellow and green.
c, Structural alignment of the H5N1 dimer and H1N1 NS1 ED^7
dimer (in ruby; PDB ID, 2GX9), demonstrating the twisting motion
(curved arrows) of the H5N1 ED monomers, with respect to H1N1
ED, towards their RBDs. Each monomer in the H5N1 NS1 dimer is
coloured as in a. The dimeric interface of the H5N1 NS1 ED
consists of a series of electrostatic interactions: a salt
bridge between K131 and E97, hydrogen-bonding involving the side
chains of T91 and R193, E196 and R200, E152 and the amide group
of L95, as well as a back-bone hydrogen bond between the E96
amide group and the E152 carbonyl group. In contrast, the
dimeric interactions in the H1N1 NS1 ED consists primarily of
strong hydrophobic interactions along the continuous
anti-parallel -sheet
involving residues L90, V136 and L141 (ref. 7).
|
 |
|
|
|
| |
The above figures are
reprinted
from an Open Access publication published by Macmillan Publishers Ltd:
Nature
(2008,
456,
985-988)
copyright 2008.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
M.ElHefnawi,
O.Alaidi,
N.Mohamed,
M.Kamar,
I.El-Azab,
S.Zada,
and
R.Siam
(2011).
Identification of novel conserved functional motifs across most Influenza A viral strains.
|
| |
Virol J,
8,
44.
|
 |
|
|
|
|
 |
P.S.Kerry,
J.Ayllon,
M.A.Taylor,
C.Hass,
A.Lewis,
A.García-Sastre,
R.E.Randall,
B.G.Hale,
and
R.J.Russell
(2011).
A transient homotypic interaction model for the influenza A virus NS1 protein effector domain.
|
| |
PLoS One,
6,
e17946.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
B.G.Hale,
P.S.Kerry,
D.Jackson,
B.L.Precious,
A.Gray,
M.J.Killip,
R.E.Randall,
and
R.J.Russell
(2010).
Structural insights into phosphoinositide 3-kinase activation by the influenza A virus NS1 protein.
|
| |
Proc Natl Acad Sci U S A,
107,
1954-1959.
|
 |
|
|
|
|
 |
B.G.Hale,
R.A.Albrecht,
and
A.García-Sastre
(2010).
Innate immune evasion strategies of influenza viruses.
|
| |
Future Microbiol,
5,
23-41.
|
 |
|
|
|
|
 |
C.Pan,
B.Cheung,
S.Tan,
C.Li,
L.Li,
S.Liu,
and
S.Jiang
(2010).
Genomic signature and mutation trend analysis of pandemic (H1N1) 2009 influenza A virus.
|
| |
PLoS One,
5,
e9549.
|
 |
|
|
|
|
 |
C.R.Kimberlin,
Z.A.Bornholdt,
S.Li,
V.L.Woods,
I.J.MacRae,
and
E.O.Saphire
(2010).
Ebolavirus VP35 uses a bimodal strategy to bind dsRNA for innate immune suppression.
|
| |
Proc Natl Acad Sci U S A,
107,
314-319.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
D.Jia,
R.Rahbar,
R.W.Chan,
S.M.Lee,
M.C.Chan,
B.X.Wang,
D.P.Baker,
B.Sun,
J.S.Peiris,
J.M.Nicholls,
and
E.N.Fish
(2010).
Influenza virus non-structural protein 1 (NS1) disrupts interferon signaling.
|
| |
PLoS One,
5,
e13927.
|
 |
|
|
|
|
 |
K.Das,
J.M.Aramini,
L.C.Ma,
R.M.Krug,
and
E.Arnold
(2010).
Structures of influenza A proteins and insights into antiviral drug targets.
|
| |
Nat Struct Mol Biol,
17,
530-538.
|
 |
|
|
|
|
 |
W.Li,
G.Wang,
H.Zhang,
G.Xin,
D.Zhang,
J.Zeng,
X.Chen,
Y.Xu,
Y.Cui,
and
K.Li
(2010).
Effects of NS1 variants of H5N1 influenza virus on interferon induction, TNFalpha response and p53 activity.
|
| |
Cell Mol Immunol,
7,
235-242.
|
 |
|
|
|
|
 |
X.Liu,
and
Y.P.Zhao
(2010).
Switch region for pathogenic structural change in conformational disease and its prediction.
|
| |
PLoS One,
5,
e8441.
|
 |
|
|
|
|
 |
Y.Li,
X.Lu,
J.Li,
N.Bérubé,
K.L.Giest,
Q.Liu,
D.H.Anderson,
and
Y.Zhou
(2010).
Genetically engineered, biarsenically labeled influenza virus allows visualization of viral NS1 protein in living cells.
|
| |
J Virol,
84,
7204-7213.
|
 |
|
|
|
|
 |
S.J.Lycett,
M.J.Ward,
F.I.Lewis,
A.F.Poon,
S.L.Kosakovsky Pond,
and
A.J.Brown
(2009).
Detection of mammalian virulence determinants in highly pathogenic avian influenza H5N1 viruses: multivariate analysis of published data.
|
| |
J Virol,
83,
9901-9910.
|
 |
|
|
|
|
 |
T.Wolff,
and
S.Ludwig
(2009).
Influenza viruses control the vertebrate type I interferon system: factors, mechanisms, and consequences.
|
| |
J Interferon Cytokine Res,
29,
549-557.
|
 |
|
|
|
|
 |
V.Darapaneni,
V.K.Prabhaker,
and
A.Kukol
(2009).
Large-scale analysis of influenza A virus sequences reveals potential drug target sites of non-structural proteins.
|
| |
J Gen Virol,
90,
2124-2133.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |